Back to mobile site
Get it on Google Play

Natera and TransCode team up on colorectal cancer MRD trial

October 13, 2026 7:30 AM EDT Send to a Friend
Natera, Inc. (Nasdaq: NTRA) and TransCode Therapeutics, Inc. (Nasdaq: RNAZ) have announced a collaboration to support patient enrollment in TransCode's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login